4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0000950170-24-071533
Options or other derivatives
- Chief Executive Officer acquired 530,647 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ceesay Abraham Chief Executive Officer | 2024-06-06 | Grant or award · Stock Option (Right to Buy) | +530,647 | 530,647 | D | ||
Loading xslF345X05/ownership.xml…